Inactive Instrument
AS Olainfarm Share Price Deutsche Boerse AG
Stocks
UU4
LV0000100501
Pharmaceuticals
| 07/22/07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/22/06 | Notification about results of final buy-back of shares | AQ |
| 30/21/30 | Notification about final share buy-back | AQ |
| 28/21/28 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/21/28 | On substantial participation (4) - specified | AQ |
| 1 day | -0.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 19/06/2021 | |
Janis Buks
CHM | Chairman | - | 01/09/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -3.46% | - | - | 15Cr | |
| -0.49% | +1.53% | +13.55% | +82.58% | 4.81TCr | |
| -1.41% | +5.55% | +70.04% | +116.16% | 3.79TCr | |
| -1.39% | -0.16% | -4.06% | +42.16% | 1.25TCr | |
| +0.44% | +2.83% | +15.18% | +96.06% | 1.2TCr | |
| +1.82% | +2.76% | +34.19% | +120.25% | 902.96Cr | |
| -0.16% | +1.91% | +22.31% | +47.95% | 724.14Cr | |
| +0.41% | +2.01% | +55.16% | -3.74% | 708.74Cr | |
| -2.81% | +17.66% | -18.38% | +20.93% | 653.53Cr | |
| -0.26% | +3.58% | +23.74% | +238.93% | 671.84Cr | |
| Average | -0.40% | +4.16% | +23.52% | +84.59% | 1.63TCr | |
| Weighted average by Cap. | -0.61% | +3.97% | +29.49% | +89.75% |
Employees
2,191
Sector
Pharmaceuticals
Choose MarketScreener 
